Women with PMOS should get subsidised weight loss drugs, advocates say
OMEGAZEPRIME News
This story was selected and curated by our editorial team in the Australia news category. Published on October 9, 2026 • Originally reported by Tess Ikonomou. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
This story was selected and curated by our editorial team in the Australia news category. Published on October 9, 2026 • Originally reported by Tess Ikonomou. OMEGAZEPRIME provides independent news coverage and analysis for our readers. Stay informed with the latest developments.
With GLP-1s to treat the condition not specifically approved by the TGA, patients are being prescribed them off-label
Get our breaking news email, free app or daily news podcast
Women living with a chronic hormonal condition should have access to taxpayer-funded weight loss medications, advocates say.
The Polyendrocrine Metabolic Ovarian Syndrome Association of Australia (POSAA) is urging for GLP-1 drugs to be approved on the Pharmaceutical Benefits Scheme for people living with the condition.
Continue reading...OMEGAZEPRIME News — For more stories and analysis, visit omegazeprime.com